| NO | LNP Formulations | mRNA | sgRNA | INDEL efficiency in test Cell lines |
|---|---|---|---|---|
| 1 | SM102-LNP | espCas9 | TRAC | HEK293T 97%, Jurkat 82%, T cells72% , HepG2 86% |
| 2 | ALC0315-LNP | espCas9 | TRAC | HEK293T 87%, Jurkat 80%, T cells 61% |
| 3 | LP01-LNP | espCas9 | TRAC | HEK293T 63%, Jurkat 75% |
| 4 | 20DODAP-LNP | espCas9 | PCSK9 | HepG2 87% |
| 5 | SM102-SOPC LNP | espCas9 | PCSK9 | HepG2 90% |
| 6 | SM102-LNP | HifiCas9 | TRAC | HEK293T 97%, T cells 61% , HepG2 88% |
| 7 | SM102-SOPC LNP | espCas9 | TRAC | HepG2 90% |
| 8 | SM102 LNP | Cas12a Ultra | TRAC | HEK293T 63% |
| 9 | SM102-Mod LNP | PEmax | HEK3 pegRNA Nicking guide RNA |
HEK293T 62% |
| 10 | CXM2-LNP | CBE | TRAC | HEK293T 34% |
| 11 | SM102-Mod LNP | CBE | TRAC | HEK293T 42% |


